Critical role of miR-125b in lipogenesis by targeting stearoyl-CoA desaturase-1 (SCD-1) 1

Alteration of gene expression tightly regulates lipogenesis. Stearoyl-CoA desaturase-1 (SCD-1), a key enzyme in lipogenesis, catalyzes the conversion of SFA to MUFA, and inhibition of its activity impairs lipid synthesis. As posttranscriptional regulators, microRNAs are involved in many pathways of...

Full description

Saved in:
Bibliographic Details
Published inJournal of animal science Vol. 94; no. 1; p. 65
Main Authors Cheng, X, Xi, Q-Y, Wei, S, Wu, D, Ye, R-S, Chen, T, Qi, Q-E, Jiang, Q-Y, Wang, S-B, Wang, L-N, Zhu, X-T, Zhang, Y-L
Format Journal Article
LanguageEnglish
Published Champaign Oxford University Press 01.01.2016
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alteration of gene expression tightly regulates lipogenesis. Stearoyl-CoA desaturase-1 (SCD-1), a key enzyme in lipogenesis, catalyzes the conversion of SFA to MUFA, and inhibition of its activity impairs lipid synthesis. As posttranscriptional regulators, microRNAs are involved in many pathways of lipid metabolism; however, their effect on SCD-1 has not been reported. In this study, miR-125b was identified as a potential regulator of SCD-1 using bioinformatics analysis. Here, we validated SCD-1 as the target of miR-125b using a dual luciferase assay. During adipogenesis, a synthetic mimic or inhibitor was used to overexpress or reduce the expression of miR-125b in porcine adipocytes. Overexpression of miR-125b reduced the accumulation of lipid droplets and triglycerides concentration and repressed SCD-1 protein expression and MUFA composition. The inhibitor had the reverse effect. Small interfering RNA against SCD-1 tested in adipocytes further proved the direct correlation between miR-125b and SCD-1. Moreover, in vivo experiments in mice showed that injection of miR-125b expression vector decreased the hepatic triglycerides concentration relative to saline. This study indicated that miR-125b regulates lipogenesis by targeting SCD-1; therefore, miR-125b might be applied in therapy of lipid metabolism disorders.
ISSN:0021-8812
1525-3163
DOI:10.2527/jas2015-9456